Review



wnt signaling pathway inhibitor xav939  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    MedChemExpress wnt signaling pathway inhibitor xav939
    Wnt Signaling Pathway Inhibitor Xav939, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 239 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt signaling pathway inhibitor xav939/product/MedChemExpress
    Average 96 stars, based on 239 article reviews
    wnt signaling pathway inhibitor xav939 - by Bioz Stars, 2026-06
    96/100 stars

    Images



    Similar Products

    96
    MedChemExpress wnt signaling pathway inhibitor xav939
    Wnt Signaling Pathway Inhibitor Xav939, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt signaling pathway inhibitor xav939/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    wnt signaling pathway inhibitor xav939 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    93
    TargetMol β catenin signaling pathway
    β Catenin Signaling Pathway, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/β catenin signaling pathway/product/TargetMol
    Average 93 stars, based on 1 article reviews
    β catenin signaling pathway - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    97
    MedChemExpress wnt signaling pathway activator laduviglusib
    Wnt Signaling Pathway Activator Laduviglusib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt signaling pathway activator laduviglusib/product/MedChemExpress
    Average 97 stars, based on 1 article reviews
    wnt signaling pathway activator laduviglusib - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    95
    MedChemExpress wnt β catenin signaling pathway activator skl2001
    Wnt β Catenin Signaling Pathway Activator Skl2001, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt β catenin signaling pathway activator skl2001/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    wnt β catenin signaling pathway activator skl2001 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress wnt β catenin pathway
    Meis1 regulated EMT <t>through</t> <t>the</t> <t>Wnt/β-catenin</t> pathway. ( A ) q-PCR analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids, ** P < .01. ( B ) Western blot analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids. ( C ) Western blot analysis of lentivirus-mediated Meis1 knockdown efficiency by shRNA in HaCaT cells. ( D ) Venn diagram showing overlapping differentially expressed genes (DEGs) between the TGF-β1-induced group and sh-Meis1-2 group (C1: the control group; C2: TGF-β1-induced group; C3: sh-Meis1-2 group). ( E ) Pathway enrichment analysis of overlapping DEGs between the TGF-β1-induced group and sh-Meis1-2 group. ( F-H ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 overexpression, * P < .05, ** P < .01. ( I ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 overexpression. ( J-L ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 knockdown, * P < .05, ** P < .01. ( M ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 knockdown. ( N ) Western blot analysis of β-catenin protein expression in cells with or without MSAB treatment. ( O ) Western blot analysis of α-SMA, Vimentin, E-cadherin, and N-cadherin protein expression in cells with or without MSAB treatment.
    Wnt β Catenin Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt β catenin pathway/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    wnt β catenin pathway - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology wnt signaling pathway inhibitor xav939
    Meis1 regulated EMT <t>through</t> <t>the</t> <t>Wnt/β-catenin</t> pathway. ( A ) q-PCR analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids, ** P < .01. ( B ) Western blot analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids. ( C ) Western blot analysis of lentivirus-mediated Meis1 knockdown efficiency by shRNA in HaCaT cells. ( D ) Venn diagram showing overlapping differentially expressed genes (DEGs) between the TGF-β1-induced group and sh-Meis1-2 group (C1: the control group; C2: TGF-β1-induced group; C3: sh-Meis1-2 group). ( E ) Pathway enrichment analysis of overlapping DEGs between the TGF-β1-induced group and sh-Meis1-2 group. ( F-H ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 overexpression, * P < .05, ** P < .01. ( I ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 overexpression. ( J-L ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 knockdown, * P < .05, ** P < .01. ( M ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 knockdown. ( N ) Western blot analysis of β-catenin protein expression in cells with or without MSAB treatment. ( O ) Western blot analysis of α-SMA, Vimentin, E-cadherin, and N-cadherin protein expression in cells with or without MSAB treatment.
    Wnt Signaling Pathway Inhibitor Xav939, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt signaling pathway inhibitor xav939/product/Yeasen Biotechnology
    Average 86 stars, based on 1 article reviews
    wnt signaling pathway inhibitor xav939 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    96
    Selleck Chemicals wnt pathway inhibitor iwp 2
    Meis1 regulated EMT <t>through</t> <t>the</t> <t>Wnt/β-catenin</t> pathway. ( A ) q-PCR analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids, ** P < .01. ( B ) Western blot analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids. ( C ) Western blot analysis of lentivirus-mediated Meis1 knockdown efficiency by shRNA in HaCaT cells. ( D ) Venn diagram showing overlapping differentially expressed genes (DEGs) between the TGF-β1-induced group and sh-Meis1-2 group (C1: the control group; C2: TGF-β1-induced group; C3: sh-Meis1-2 group). ( E ) Pathway enrichment analysis of overlapping DEGs between the TGF-β1-induced group and sh-Meis1-2 group. ( F-H ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 overexpression, * P < .05, ** P < .01. ( I ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 overexpression. ( J-L ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 knockdown, * P < .05, ** P < .01. ( M ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 knockdown. ( N ) Western blot analysis of β-catenin protein expression in cells with or without MSAB treatment. ( O ) Western blot analysis of α-SMA, Vimentin, E-cadherin, and N-cadherin protein expression in cells with or without MSAB treatment.
    Wnt Pathway Inhibitor Iwp 2, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wnt pathway inhibitor iwp 2/product/Selleck Chemicals
    Average 96 stars, based on 1 article reviews
    wnt pathway inhibitor iwp 2 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    93
    Selleck Chemicals canonical wnt pathway activator
    (A) Schematic representation of the R26-WntVis reporter. H2B–EGFP expression is driven by seven tandem TCF/LEF binding elements upstream of a minimal thymidine kinase promoter, enabling visualization of <t>canonical</t> <t>Wnt/β-catenin</t> signaling activity. (B) Sagittal frozen sections from R26-WntVis mice at postnatal day 14 (P14) were analyzed by fluorescence microscopy. H2B–EGFP–positive nuclei are enriched in the superficial (sz; open arrowheads) and fibrocartilage (fc; closed arrowheads) zones and largely absent from the deeper chondrocartilage (cc) zone, indicating spatial restriction of canonical Wnt activity to the upper compartments. Dashed boxes indicate regions shown at higher magnification. Scale bar, 100 µm. Data are representative of three biologically independent mice. (C) Single-cell RNA sequencing was performed on enzymatically dissociated mandibular condylar cartilage from P16 R26-WntVis mice. Uniform Manifold Approximation and Projection (UMAP) visualization identified nine transcriptionally distinct clusters following quality control filtering and shared nearest neighbor clustering. (D) Feature plots show expression of representative marker genes used to annotate fibrocartilage ( Col1a1 ) and chondrocartilage ( Col2a1 ) populations, enabling classification of major cartilage compartments. (E) Feature plot and dot plot analyses were used to examine H2B–EGFP reporter expression across clusters. Cluster 5 shows marked enrichment of H2B–EGFP–positive cells and was designated as the MC-progenitor cluster, indicating a Wnt-responsive progenitor-like population. (F) KEGG <t>pathway</t> enrichment analysis was performed on differentially expressed genes in the MC-progenitor cluster relative to differentiated cartilage clusters. Cell-cycle–associated pathways are significantly enriched, consistent with a proliferative transcriptional state. (G) Trajectory inference was performed using Monocle3 to assess lineage relationships among clusters. The MC-progenitor cluster (cluster 5) is positioned at the root of a bifurcating trajectory leading toward fibrocartilage and chondrocartilage lineages, supporting its role as an upstream progenitor population.
    Canonical Wnt Pathway Activator, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/canonical wnt pathway activator/product/Selleck Chemicals
    Average 93 stars, based on 1 article reviews
    canonical wnt pathway activator - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    95
    MedChemExpress canonical wnt pathway
    HA-induced activation of the <t>canonical</t> <t>Wnt</t> <t>pathway</t> upregulates FOSL2 to expand the dNK1-like subpopulation. (A) Analysis of transcriptional activity and expression levels of transcription factors in three dNK subsets using scRNA-seq data from normal decidual tissue ( n = 11). (B) Transcriptional activity and expression levels of FOSL2 in decidual tissues from normal pregnancy ( n = 5) and RSA groups ( n = 3). (C) Changes in NK92MI cells of the five transcription factors ( STAT3, MAFB, HES1, FOSL2, ETV5 ) characterized by high transcriptional activity and expression in the dNK1 subset following HMW-HA treatment, as determined by RT−qPCR ( n = 6 per group). (D) FOSL2 expression in NK92MI cells following HMW-HA treatment, assessed by WB ( n = 3 per group). (E) Wnt1 and β-catenin protein expression in NK92MI cells treated with or without HMW-HA in the presence or absence of CD44 blockade ( n = 3 per group). (F) FOSL2 expression in HA−treated NK92MI cells after addition of CD44−blocking antibody or the Wnt pathway <t>inhibitor</t> IWP−2 to the culture system ( n = 3 per group). Data are expressed as mean ± SD; * P < 0.05; ** P < 0.01; ns, not significant. EP, early pregnancy; SA, spontaneous abortion; RSA, recurrent spontaneous abortion.
    Canonical Wnt Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/canonical wnt pathway/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    canonical wnt pathway - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    86
    Routledge Ltd int wnt signaling pathway
    HA-induced activation of the <t>canonical</t> <t>Wnt</t> <t>pathway</t> upregulates FOSL2 to expand the dNK1-like subpopulation. (A) Analysis of transcriptional activity and expression levels of transcription factors in three dNK subsets using scRNA-seq data from normal decidual tissue ( n = 11). (B) Transcriptional activity and expression levels of FOSL2 in decidual tissues from normal pregnancy ( n = 5) and RSA groups ( n = 3). (C) Changes in NK92MI cells of the five transcription factors ( STAT3, MAFB, HES1, FOSL2, ETV5 ) characterized by high transcriptional activity and expression in the dNK1 subset following HMW-HA treatment, as determined by RT−qPCR ( n = 6 per group). (D) FOSL2 expression in NK92MI cells following HMW-HA treatment, assessed by WB ( n = 3 per group). (E) Wnt1 and β-catenin protein expression in NK92MI cells treated with or without HMW-HA in the presence or absence of CD44 blockade ( n = 3 per group). (F) FOSL2 expression in HA−treated NK92MI cells after addition of CD44−blocking antibody or the Wnt pathway <t>inhibitor</t> IWP−2 to the culture system ( n = 3 per group). Data are expressed as mean ± SD; * P < 0.05; ** P < 0.01; ns, not significant. EP, early pregnancy; SA, spontaneous abortion; RSA, recurrent spontaneous abortion.
    Int Wnt Signaling Pathway, supplied by Routledge Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/int wnt signaling pathway/product/Routledge Ltd
    Average 86 stars, based on 1 article reviews
    int wnt signaling pathway - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Meis1 regulated EMT through the Wnt/β-catenin pathway. ( A ) q-PCR analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids, ** P < .01. ( B ) Western blot analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids. ( C ) Western blot analysis of lentivirus-mediated Meis1 knockdown efficiency by shRNA in HaCaT cells. ( D ) Venn diagram showing overlapping differentially expressed genes (DEGs) between the TGF-β1-induced group and sh-Meis1-2 group (C1: the control group; C2: TGF-β1-induced group; C3: sh-Meis1-2 group). ( E ) Pathway enrichment analysis of overlapping DEGs between the TGF-β1-induced group and sh-Meis1-2 group. ( F-H ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 overexpression, * P < .05, ** P < .01. ( I ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 overexpression. ( J-L ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 knockdown, * P < .05, ** P < .01. ( M ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 knockdown. ( N ) Western blot analysis of β-catenin protein expression in cells with or without MSAB treatment. ( O ) Western blot analysis of α-SMA, Vimentin, E-cadherin, and N-cadherin protein expression in cells with or without MSAB treatment.

    Journal: International Dental Journal

    Article Title: Meis1 Negatively Regulates Epithelial-Mesenchymal Transition via Wnt/β-catenin Pathway in Oral Submucous Fibrosis

    doi: 10.1016/j.identj.2025.109323

    Figure Lengend Snippet: Meis1 regulated EMT through the Wnt/β-catenin pathway. ( A ) q-PCR analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids, ** P < .01. ( B ) Western blot analysis of Meis1 knockdown efficiency in HaCaT cells transfected with sh-Meis1 plasmids. ( C ) Western blot analysis of lentivirus-mediated Meis1 knockdown efficiency by shRNA in HaCaT cells. ( D ) Venn diagram showing overlapping differentially expressed genes (DEGs) between the TGF-β1-induced group and sh-Meis1-2 group (C1: the control group; C2: TGF-β1-induced group; C3: sh-Meis1-2 group). ( E ) Pathway enrichment analysis of overlapping DEGs between the TGF-β1-induced group and sh-Meis1-2 group. ( F-H ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 overexpression, * P < .05, ** P < .01. ( I ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 overexpression. ( J-L ) q-PCR analysis of β-catenin, cyclin D1, and c-Myc mRNA expression in cells with Meis1 knockdown, * P < .05, ** P < .01. ( M ) Western blot analysis of β-catenin, c-Jun, c-Myc, and cyclin D1 protein expression in cells with Meis1 knockdown. ( N ) Western blot analysis of β-catenin protein expression in cells with or without MSAB treatment. ( O ) Western blot analysis of α-SMA, Vimentin, E-cadherin, and N-cadherin protein expression in cells with or without MSAB treatment.

    Article Snippet: MSAB was used to treat HaCaT cells by blocking the Wnt/β-catenin pathway (MCE, HY-120697).

    Techniques: Knockdown, Transfection, Western Blot, shRNA, Control, Expressing, Over Expression

    (A) Schematic representation of the R26-WntVis reporter. H2B–EGFP expression is driven by seven tandem TCF/LEF binding elements upstream of a minimal thymidine kinase promoter, enabling visualization of canonical Wnt/β-catenin signaling activity. (B) Sagittal frozen sections from R26-WntVis mice at postnatal day 14 (P14) were analyzed by fluorescence microscopy. H2B–EGFP–positive nuclei are enriched in the superficial (sz; open arrowheads) and fibrocartilage (fc; closed arrowheads) zones and largely absent from the deeper chondrocartilage (cc) zone, indicating spatial restriction of canonical Wnt activity to the upper compartments. Dashed boxes indicate regions shown at higher magnification. Scale bar, 100 µm. Data are representative of three biologically independent mice. (C) Single-cell RNA sequencing was performed on enzymatically dissociated mandibular condylar cartilage from P16 R26-WntVis mice. Uniform Manifold Approximation and Projection (UMAP) visualization identified nine transcriptionally distinct clusters following quality control filtering and shared nearest neighbor clustering. (D) Feature plots show expression of representative marker genes used to annotate fibrocartilage ( Col1a1 ) and chondrocartilage ( Col2a1 ) populations, enabling classification of major cartilage compartments. (E) Feature plot and dot plot analyses were used to examine H2B–EGFP reporter expression across clusters. Cluster 5 shows marked enrichment of H2B–EGFP–positive cells and was designated as the MC-progenitor cluster, indicating a Wnt-responsive progenitor-like population. (F) KEGG pathway enrichment analysis was performed on differentially expressed genes in the MC-progenitor cluster relative to differentiated cartilage clusters. Cell-cycle–associated pathways are significantly enriched, consistent with a proliferative transcriptional state. (G) Trajectory inference was performed using Monocle3 to assess lineage relationships among clusters. The MC-progenitor cluster (cluster 5) is positioned at the root of a bifurcating trajectory leading toward fibrocartilage and chondrocartilage lineages, supporting its role as an upstream progenitor population.

    Journal: bioRxiv

    Article Title: A Wnt-responsive fibrocartilage progenitor system coordinates postnatal mandibular condylar cartilage growth

    doi: 10.64898/2026.03.25.714159

    Figure Lengend Snippet: (A) Schematic representation of the R26-WntVis reporter. H2B–EGFP expression is driven by seven tandem TCF/LEF binding elements upstream of a minimal thymidine kinase promoter, enabling visualization of canonical Wnt/β-catenin signaling activity. (B) Sagittal frozen sections from R26-WntVis mice at postnatal day 14 (P14) were analyzed by fluorescence microscopy. H2B–EGFP–positive nuclei are enriched in the superficial (sz; open arrowheads) and fibrocartilage (fc; closed arrowheads) zones and largely absent from the deeper chondrocartilage (cc) zone, indicating spatial restriction of canonical Wnt activity to the upper compartments. Dashed boxes indicate regions shown at higher magnification. Scale bar, 100 µm. Data are representative of three biologically independent mice. (C) Single-cell RNA sequencing was performed on enzymatically dissociated mandibular condylar cartilage from P16 R26-WntVis mice. Uniform Manifold Approximation and Projection (UMAP) visualization identified nine transcriptionally distinct clusters following quality control filtering and shared nearest neighbor clustering. (D) Feature plots show expression of representative marker genes used to annotate fibrocartilage ( Col1a1 ) and chondrocartilage ( Col2a1 ) populations, enabling classification of major cartilage compartments. (E) Feature plot and dot plot analyses were used to examine H2B–EGFP reporter expression across clusters. Cluster 5 shows marked enrichment of H2B–EGFP–positive cells and was designated as the MC-progenitor cluster, indicating a Wnt-responsive progenitor-like population. (F) KEGG pathway enrichment analysis was performed on differentially expressed genes in the MC-progenitor cluster relative to differentiated cartilage clusters. Cell-cycle–associated pathways are significantly enriched, consistent with a proliferative transcriptional state. (G) Trajectory inference was performed using Monocle3 to assess lineage relationships among clusters. The MC-progenitor cluster (cluster 5) is positioned at the root of a bifurcating trajectory leading toward fibrocartilage and chondrocartilage lineages, supporting its role as an upstream progenitor population.

    Article Snippet: Pharmacological treatments were performed using the Foxm1 inhibitor RCM-1, the β-catenin inhibitor XAV-939, or a canonical Wnt pathway activator (Wnt agonist 1) (all from Selleck Chemicals, Japan).

    Techniques: Expressing, Binding Assay, Activity Assay, Fluorescence, Microscopy, Single Cell, RNA Sequencing, Control, Marker

    Isolated Wnt-responsive cells were cultured in vitro and treated with the Wnt pathway inhibitor XAV-939 (1 μM or 5 μM), the Foxm1 inhibitor RCM-1 (4 μM or 20 μM), or the Wnt agonist Wnt agonist 1 (0.2 nM or 1 nM). Cell proliferation was quantified by measuring total cell number after treatment. Pharmacological inhibition of canonical Wnt signaling using XAV-939 significantly reduced cell expansion compared with control cultures. Similarly, inhibition of Foxm1 using RCM-1 markedly suppressed proliferation. In contrast, activation of canonical Wnt signaling by Wnt agonist 1 increased cell numbers relative to controls. These findings support a cooperative role for canonical Wnt signaling and Foxm1 in promoting proliferative capacity of Wnt-responsive cells in vitro . Bars represent mean ± s.d. Each dot represents one biologically independent sample. Statistical significance was determined by one-way ANOVA followed by multiple comparisons testing. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Journal: bioRxiv

    Article Title: A Wnt-responsive fibrocartilage progenitor system coordinates postnatal mandibular condylar cartilage growth

    doi: 10.64898/2026.03.25.714159

    Figure Lengend Snippet: Isolated Wnt-responsive cells were cultured in vitro and treated with the Wnt pathway inhibitor XAV-939 (1 μM or 5 μM), the Foxm1 inhibitor RCM-1 (4 μM or 20 μM), or the Wnt agonist Wnt agonist 1 (0.2 nM or 1 nM). Cell proliferation was quantified by measuring total cell number after treatment. Pharmacological inhibition of canonical Wnt signaling using XAV-939 significantly reduced cell expansion compared with control cultures. Similarly, inhibition of Foxm1 using RCM-1 markedly suppressed proliferation. In contrast, activation of canonical Wnt signaling by Wnt agonist 1 increased cell numbers relative to controls. These findings support a cooperative role for canonical Wnt signaling and Foxm1 in promoting proliferative capacity of Wnt-responsive cells in vitro . Bars represent mean ± s.d. Each dot represents one biologically independent sample. Statistical significance was determined by one-way ANOVA followed by multiple comparisons testing. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Article Snippet: Pharmacological treatments were performed using the Foxm1 inhibitor RCM-1, the β-catenin inhibitor XAV-939, or a canonical Wnt pathway activator (Wnt agonist 1) (all from Selleck Chemicals, Japan).

    Techniques: Isolation, Cell Culture, In Vitro, Inhibition, Control, Activation Assay

    HA-induced activation of the canonical Wnt pathway upregulates FOSL2 to expand the dNK1-like subpopulation. (A) Analysis of transcriptional activity and expression levels of transcription factors in three dNK subsets using scRNA-seq data from normal decidual tissue ( n = 11). (B) Transcriptional activity and expression levels of FOSL2 in decidual tissues from normal pregnancy ( n = 5) and RSA groups ( n = 3). (C) Changes in NK92MI cells of the five transcription factors ( STAT3, MAFB, HES1, FOSL2, ETV5 ) characterized by high transcriptional activity and expression in the dNK1 subset following HMW-HA treatment, as determined by RT−qPCR ( n = 6 per group). (D) FOSL2 expression in NK92MI cells following HMW-HA treatment, assessed by WB ( n = 3 per group). (E) Wnt1 and β-catenin protein expression in NK92MI cells treated with or without HMW-HA in the presence or absence of CD44 blockade ( n = 3 per group). (F) FOSL2 expression in HA−treated NK92MI cells after addition of CD44−blocking antibody or the Wnt pathway inhibitor IWP−2 to the culture system ( n = 3 per group). Data are expressed as mean ± SD; * P < 0.05; ** P < 0.01; ns, not significant. EP, early pregnancy; SA, spontaneous abortion; RSA, recurrent spontaneous abortion.

    Journal: Frontiers in Immunology

    Article Title: Hyaluronic acid−CD44 signaling from decidual stromal cells orchestrates dNK1 differentiation and immune tolerance in early pregnancy

    doi: 10.3389/fimmu.2026.1777567

    Figure Lengend Snippet: HA-induced activation of the canonical Wnt pathway upregulates FOSL2 to expand the dNK1-like subpopulation. (A) Analysis of transcriptional activity and expression levels of transcription factors in three dNK subsets using scRNA-seq data from normal decidual tissue ( n = 11). (B) Transcriptional activity and expression levels of FOSL2 in decidual tissues from normal pregnancy ( n = 5) and RSA groups ( n = 3). (C) Changes in NK92MI cells of the five transcription factors ( STAT3, MAFB, HES1, FOSL2, ETV5 ) characterized by high transcriptional activity and expression in the dNK1 subset following HMW-HA treatment, as determined by RT−qPCR ( n = 6 per group). (D) FOSL2 expression in NK92MI cells following HMW-HA treatment, assessed by WB ( n = 3 per group). (E) Wnt1 and β-catenin protein expression in NK92MI cells treated with or without HMW-HA in the presence or absence of CD44 blockade ( n = 3 per group). (F) FOSL2 expression in HA−treated NK92MI cells after addition of CD44−blocking antibody or the Wnt pathway inhibitor IWP−2 to the culture system ( n = 3 per group). Data are expressed as mean ± SD; * P < 0.05; ** P < 0.01; ns, not significant. EP, early pregnancy; SA, spontaneous abortion; RSA, recurrent spontaneous abortion.

    Article Snippet: To determine the signaling pathways involved, we used an anti-CD44 blocking antibody (30 μg/mL; BioxCell, BE0262) to block CD44, and IWP-2 (50 μM; MedChemExpress, HY-13912) to inhibit the canonical Wnt pathway.

    Techniques: Activation Assay, Activity Assay, Expressing, Quantitative RT-PCR, Blocking Assay